1
Matthew W Bootman, Ronald K Yamamoto: Self-sealing subcutaneous injection site. American Hospital Supply Corporation, Roger A Williams, September 24, 1985: US04543088 (276 worldwide citation)

A self-sealing subcutaneous injection site for implantation in the body includes a housing having a bottom wall and a generally resilient dome-shaped wall which defines an interior chamber within the housing. The interior chamber has a durometer and shape for providing compressive forces within the ...


2
Philip N Sawyer, Donald G Wallace, Ronald K Yamamoto: Method for bonding or fusion of biological tissue and material. Fusion Medical Technologies, Townsend and Townsend and Crew, May 12, 1998: US05749895 (202 worldwide citation)

Biological materials are joined, repaired or fused by heating the material in proximity to a mechanical support. Preferably, the mechanical support comprises a patch or bridge structure. In the most preferred embodiment, the patch is formed from collagen having a thickness from between 2 to 30 mils, ...


3
Ronald K Yamamoto, Stanley R Conston, Matthew Bootman: Percutaneous access device. Vitaphore Corporation, Heller Ehrman White & McAuliffe, October 22, 1991: US05059186 (167 worldwide citation)

A percutaneous access device for aseptically introducing catheters or other tubes into the body, is disclosed. In one aspect, the device comprises a valve housing having a tapered inner bore; a tapered tubular valve means which is inserted into the valve housing bore and comprises one or two valves; ...


4
Michael K Kwan, Stephen D Pacetti, Ronald K Yamamoto: Bone grafting matrix. Orquest, Fish & Richardson P C, July 7, 1998: US05776193 (131 worldwide citation)

A porous three-dimensional bone grafting matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix and having a particle size of 5 microns or less.


5
Ronald K Yamamoto, Sophia Pesotchinsky: Positionable tissue interfacing device for the management of percutaneous conduits. Vitaphore Corporation, Christie Parker & Hale, June 30, 1987: US04676782 (112 worldwide citation)

This invention is a sleeve-like tissue-interface device designed to reduce the incidence of nosocomial infection related to percutaneous conduits by promoting a tissue seal where the conduit and skin interface, and by the expression of antibacterial activity to reduce the possibility of bacteria adv ...


6
Michael K Kwan, Stephen D Pacetti, Ronald K Yamamoto: Bone grafting matrix. Orquest, Fish & Richardson PC, February 13, 2001: US06187047 (79 worldwide citation)

A porous three-dimensional bone grafting matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix and having a particle size of 5 microns or less.


7
Stanley R Conston, Ronald K Yamamoto, Jodi J Akin, Gitanjali V Barry: Devices and methods for interconnecting vessels. BioConnect Systems, Kilpatrick Townsend & Stockton, February 22, 2011: US07892247 (68 worldwide citation)

The present invention provides implantable devices and associated methods for interconnecting human vessels in a side-to-side or an end-to-side arrangement rapidly, safely and in a minimally invasive manner. The devices comprise a vessel connector and a intravascular support mechanism for establishi ...


8
Jodi Akin, Amr Salahieh, Michael Mack, Hani Shennib, Jackson Demond, Ronald K Yamamoto, Stanley R Conston: Devices and methods for interconnecting vessels. Vasconnect, Carol LaSalle, Bozicevic Field & Francis, October 1, 2002: US06458140 (64 worldwide citation)

The present invention provides implantable devices and associated methods forinterconnecting human vessels in a side-to-side or an end-to-side arrangement rapidly, safely and in a minimally invasive manner. The devices comprises at least a first segment, a second component, and a flow opening betwee ...


9
Ronald K Yamamoto, Robert E Short: Microparticulate surgical adhesive. Point Medical Corporation, Fish & Richardson P C, September 7, 1999: US05948427 (57 worldwide citation)

Flowable polymeric microparticulate surgical adhesive formulations are provided which can be activated at the site of the repair to produce a cohesive material with tissue bonding properties to adjacent tissues. The formulation may be activated at the site of repair by mechanical shear forces, heat, ...


10
Gregory S Dapper, Ronald K Yamamoto: Method for forming controlled release polymeric substrate. Vitaphore Corporation, Fish & Richardson, January 30, 1996: US05487895 (52 worldwide citation)

A method for forming a controlled release polymeric substrate is provided by contacting a polymeric substrate with a liquid mixture containing a cross-linking agent at least partially soluble therein comprising water and an organic liquid, for a period of time and at a temperature and concentration ...